These three stocks defied a sharp decline in the stock market. Find out why.
News & Analysis: St. Jude Medical
Abbott agrees to buy the medical-device maker.
As a minnow among sharks, Abiomed shares are rightfully volatile. Here's why this Fool expects it to survive and thrive.
Growth and solid financial footing may be intriguing to an acquirer, but valuation may keep buyers away.
An FDA approval could lead to greater use of its Impella heart pumps.
Growing use of Impella products in heart surgery is sparking sales and profit.
Sales and dividend growth at these five companies could make them top stocks to own.
Obamacare has a few twists headed into the new year. Here's what you need to know.
St. Jude Medical investors have been pleased with this company's progress over the past year, but did the device maker's Q2 shed light on this company's direction?
St. Jude Medical, Abbott Laboratories, Eli Lilly, and Pfizer are the top health care stocks to watch this morning.